chr16-11548820-T-TA
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001136472.2(LITAF):c.*816dupT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 451,982 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
LITAF
NM_001136472.2 3_prime_UTR
NM_001136472.2 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.13
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000264 (40/151230) while in subpopulation NFE AF = 0.000413 (28/67800). AF 95% confidence interval is 0.000293. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 40 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LITAF | ENST00000622633 | c.*816dupT | 3_prime_UTR_variant | Exon 4 of 4 | 1 | NM_001136472.2 | ENSP00000483114.1 | |||
LITAF | ENST00000339430 | c.*816dupT | 3_prime_UTR_variant | Exon 4 of 4 | 1 | ENSP00000340118.5 | ||||
LITAF | ENST00000571688 | c.*816dupT | 3_prime_UTR_variant | Exon 4 of 4 | 1 | ENSP00000459533.1 | ||||
LITAF | ENST00000413364 | c.*941dupT | 3_prime_UTR_variant | Exon 5 of 5 | 2 | ENSP00000397958.2 |
Frequencies
GnomAD3 genomes AF: 0.000264 AC: 40AN: 151230Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
40
AN:
151230
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000201 AC: 26AN: 129082 AF XY: 0.000255 show subpopulations
GnomAD2 exomes
AF:
AC:
26
AN:
129082
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000186 AC: 56AN: 300752Hom.: 0 Cov.: 0 AF XY: 0.000216 AC XY: 37AN XY: 171462 show subpopulations
GnomAD4 exome
AF:
AC:
56
AN:
300752
Hom.:
Cov.:
0
AF XY:
AC XY:
37
AN XY:
171462
Gnomad4 AFR exome
AF:
AC:
4
AN:
8404
Gnomad4 AMR exome
AF:
AC:
1
AN:
27066
Gnomad4 ASJ exome
AF:
AC:
0
AN:
10752
Gnomad4 EAS exome
AF:
AC:
0
AN:
9208
Gnomad4 SAS exome
AF:
AC:
8
AN:
59290
Gnomad4 FIN exome
AF:
AC:
0
AN:
12352
Gnomad4 NFE exome
AF:
AC:
42
AN:
158552
Gnomad4 Remaining exome
AF:
AC:
1
AN:
13982
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000264 AC: 40AN: 151230Hom.: 0 Cov.: 31 AF XY: 0.000230 AC XY: 17AN XY: 73830 show subpopulations
GnomAD4 genome
AF:
AC:
40
AN:
151230
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
73830
Gnomad4 AFR
AF:
AC:
0.000218394
AN:
0.000218394
Gnomad4 AMR
AF:
AC:
0.000132066
AN:
0.000132066
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000412979
AN:
0.000412979
Gnomad4 OTH
AF:
AC:
0.000481696
AN:
0.000481696
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease, type I Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at